These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. Smolen JS; Schoels M; Aletaha D Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis. Katchamart W; Benjamanukul S; Chiowchanwesawakit P Int J Rheum Dis; 2014 Feb; 17(2):181-5. PubMed ID: 24618364 [TBL] [Abstract][Full Text] [Related]
6. An overview of low disease activity and remission in psoriatic arthritis. Lubrano E; Perrotta FM; Kavanaugh A Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S51-4. PubMed ID: 26470835 [TBL] [Abstract][Full Text] [Related]
7. A review of disease activity measures for psoriatic arthritis: what is the best approach? Her M; Kavanaugh A Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300 [TBL] [Abstract][Full Text] [Related]
8. The assessment of disease activity and outcomes in psoriatic arthritis. Kavanaugh A; Cassell S Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S142-7. PubMed ID: 16273798 [TBL] [Abstract][Full Text] [Related]
9. Outcome measures in psoriatic arthritis clinical trials. Reddy SM; Bingham III CO Curr Rheumatol Rep; 2005 Aug; 7(4):299-305. PubMed ID: 16045833 [TBL] [Abstract][Full Text] [Related]
10. Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis. Ferguson EG; Coates LC Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-113-7. PubMed ID: 25365099 [TBL] [Abstract][Full Text] [Related]
11. Psoriatic arthritis assessment tools in clinical trials. Mease PJ; Antoni CE; Gladman DD; Taylor WJ Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937 [TBL] [Abstract][Full Text] [Related]
13. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy. Chandran V; Maharaj AB Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494 [TBL] [Abstract][Full Text] [Related]
14. Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study. Desthieux C; Granger B; Balanescu AR; Balint P; Braun J; Canete JD; Heiberg T; Helliwell PS; Kalyoncu U; Kvien TK; Kiltz U; Niedermayer D; Otsa K; Scrivo R; Smolen J; Stamm TA; Veale DJ; de Vlam K; de Wit M; Gossec L Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1606-1611. PubMed ID: 27998026 [TBL] [Abstract][Full Text] [Related]
15. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis. Husted J; Gladman DD; Long JA; Farewell VT J Rheumatol; 1996 Nov; 23(11):1932-7. PubMed ID: 8923369 [TBL] [Abstract][Full Text] [Related]
20. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]